NCT01842100View on ClinicalTrials.gov

To Compare the Strategies of Universal Antibiotic Prophylaxis Versus Screen-and-treat in Reducing Infective Complications and Re-infection in Women Who Undergo Termination of Pregnancy

NACompletedINTERVENTIONAL

Enrollment

2,193

Participants

Timeline

Start Date

September 30, 1999

Primary Completion Date

February 28, 2006

Study Completion Date

February 28, 2006

Conditions

Induced AbortionPostaboral Pelvic Inflammatory DiseaseSexually Transmitted Infections

Interventions

DRUG

Universal antibiotic prophylaxis

100 mg twice daily for 7 days starting on the day of induced abortion

OTHER

Screen-and-treat

Specific antibiotic treatment was only given if the women was found to have sexually transmitted infection(s) on screening.

Trial Locations (1)

Unknown

Queen Mary Hospital, Hong Kong

All Listed Sponsors

lead

The University of Hong Kong

OTHER

NCT01842100 - To Compare the Strategies of Universal Antibiotic Prophylaxis Versus Screen-and-treat in Reducing Infective Complications and Re-infection in Women Who Undergo Termination of Pregnancy | Biotech Hunter | Biotech Hunter